Search

everythinglearnresearchcommunity

for

Search:↓

Research 10 of 319

1. Advances in the Management of Cutaneous Toxicities of Targeted Therapies Seminars in Oncology · 2012 · 42 citations
2. Dermatologic Side Effects of Systemic Targeted Anticancer Therapy Springer eBooks · 2018
3. Cutaneous adverse effects of targeted therapies Journal of the American Academy of Dermatology · 2015 · 192 citations
4. Nilotinib-Induced Keratosis Pilaris Case Reports in Dermatology · 2016 · 19 citations
5. Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib Journal of clinical medicine · 2023
6. Unusual Presentation of Childhood Leukemia With Vaginal Bleeding: A Case Report Case Reports in Hematology · 2025
7. A Case of Inflammatory Nonscarring Alopecia Associated With the Tyrosine Kinase Inhibitor Nilotinib JAMA Dermatology · 2013 · 16 citations
8. [4-t-Butylphenyl]-N-(4-imidazol-1-yl phenyl)sulfonamide (ISCK03) inhibits SCF/c-kit signaling in 501mel human melanoma cells and abolishes melanin production in mice and brownish guinea pigs Biochemical Pharmacology · 2007 · 26 citations
9. Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology Clinical & Translational Oncology · 2018 · 26 citations
10. The PDGF/PDGFR pathway as a drug target Molecular Aspects of Medicine · 2017 · 182 citations

Community

— no results